MedTrace Logo

Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System

NCT04794478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 482

Last updated 2022-02-18

No results posted yet for this study

Summary

Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System

Conditions

Interventions

DEVICE

Dexcom Continuous Glucose Monitoring System

Dexcom Continuous Glucose Monitoring System

Sponsors & Collaborators

  • DexCom, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-19
Primary Completion
2021-08-09
Completion
2021-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04794478 on ClinicalTrials.gov